GUTS — FRACTYL HEALTH, INC.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1572616 ·
Last close
$0.97
Market Cap
$12.81M
52W High
$29.34
52W Low
$0.80
ADV30
875,982
Next earnings
2026-11-12
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The company also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -18,649,000 -14,150,000 65,925,000 31,515,000 79,141,000
Jun 2026 0 0 -19,096,000 -25,538,000 81,976,000 47,140,000 83,641,000
Mar 2026 0 — -20,820,000 9,218,000 99,385,000 63,168,000 78,008,000
Dec 2025 0 0 -23,284,000 -43,727,000 121,402,000 81,540,000 111,944,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-82,428,000
Investing CF
$-11,000
Financing CF
$107,288,000
CapEx
$-557,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.10
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-572,584,000
Inventory
$0
Receivables
—
ST Investments
—
EBIT TTM
$-85,894,000
Pretax Income TTM
$-105,650,000
Interest Exp TTM
—
Analysts
4

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -96,816,000 -140,954,000 121,402,000 111,944,000 9,458,000 -90,328,000
Dec 2024 93,000 -93,531,000 -68,694,000 108,077,000 79,653,000 28,424,000 -65,521,000
Dec 2023 120,000 -50,836,000 -77,091,000 76,212,000 401,274,000 -325,062,000 -42,823,000
Dec 2022 0 -49,385,000 -46,453,000 60,956,000 313,275,000 -252,319,000 -46,243,000

TTM Snapshot

Revenues TTM
$295,000
NetIncome TTM
$-105,650,000
OpCashFlow TTM
—
Assets (Latest)
$81,976,000
Forward EPS
$-4.04

Peers — same industry

TickerNameMarket CapLastDaily %
DRIO DarioHealth Corp. $12.98M $1.15 —
PETV PetVivo Holdings, Inc. $13.28M $0.35 —
IRIX IRIDEX CORP $12.29M $0.70 —
UEEC United Health Products, Inc. $12.08M $0.05 —
CTSO Cytosorbents Corp $14.24M $4.52 —

News headlines (Yahoo Finance, 1h cache)

Fractyl Health, Inc. Common Stock Q3 2026 Earnings Call Summary
2026-11-13 13:30 · Yahoo
Fractyl Health (GUTS) Q3 2026 Earnings Call Transcript
2026-11-13 05:59 · Yahoo
Fractyl Health Inc (GUTS) Q3 2026 Earnings Call Highlights: Revita Hits Key Endpoint as ...
2026-11-13 05:04 · Yahoo
Fractyl Health Reports Third Quarter 2026 Financial Results and Business Updates
2026-11-12 21:05 · Yahoo
Fractyl Health to Report Third Quarter 2026 Financial Results and Provide Business Updates on November 12, 2026
2026-11-06 12:00 · Yahoo
Fractyl Health (GUTS) Stock Fair Value Falls After Mixed Revita Analyst Reactions
2026-11-05 19:09 · Yahoo
Fractyl Health Strengthens Revita Patent Portfolio as It Advances Toward FDA Submission and Potential Commercialization
2026-10-30 11:00 · Yahoo
Fractyl Health Announces Market Research Highlighting Substantial Patient Interest in a One-Time Procedural Approach to Post-GLP-1 Weight Maintenance
2026-10-29 11:00 · Yahoo
Fractyl Health (GUTS) Stock Sees Fair Value Cut After Mixed Revita Analyst Reactions
2026-10-22 13:11 · Yahoo
Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight Maintenance
2026-10-22 11:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.